Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 7:15 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 73–96 of 134 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: In vitro Diagnostic Clear all

Conditions: Infertility
Interventions: Trophectoderm biopsy, Cryopreservation, Embryo Transfer; Procedure
Lead sponsor: Yale University; Other
Eligibility: 18 Years to 42 Years · Female only
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 3
States / cities: San Francisco, California • Oklahoma City, Oklahoma • Philadelphia, Pennsylvania

Conditions: Asthma
Interventions: Not listed
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years to 55 Years
Enrollment: 44 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2017
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Breast Cancer, Colon Cancer, Pancreatic Cancer, Ovarian Cancer, Lung Cancer
Interventions: EXoPred; Diagnostic Test
Lead sponsor: EXoPERT; Industry
Eligibility: 45 Years and older
Enrollment: 1,400 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 9
States / cities: Long Beach, California • Los Angeles, California • Honolulu, Hawaii + 6 more

Conditions: Muscle-Invasive Bladder Carcinoma
Interventions: C2i Test; Diagnostic Test
Lead sponsor: C2i Genomics; Industry
Eligibility: 22 Years to 100 Years
Enrollment: 3 participants
Timeline: 2022
U.S. locations: 1
States / cities: Bloomfield, New Jersey

Conditions: Oral Squamous Cell Carcinoma
Interventions: saliva collection prior to clinically driven oral biopsy; Other
Lead sponsor: PeriRx; Industry
Eligibility: 18 Years and older
Enrollment: 370 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2018
U.S. locations: 5
States / cities: Chicago, Illinois • Ann Arbor, Michigan • East Lansing, Michigan + 2 more

Conditions: Malignancy, Fertility
Interventions: Tissue sample storage; Other
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 18 Years to 41 Years · Female only
Enrollment: 25 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2025
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Bladder Cancer
Interventions: Xpert Bladder Cancer Monitor; Device
Lead sponsor: Cepheid; Industry
Eligibility: 40 Years to 100 Years
Enrollment: 424 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 11
States / cities: Palo Alto, California • Denver, Colorado • Englewood, Colorado + 8 more

Conditions: Infertility
Interventions: Not listed
Lead sponsor: Progyny, Inc.; Industry
Eligibility: 18 Years to 43 Years · Female only
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Bryn Mawr, Pennsylvania

Conditions: Diabetic Kidney Disease
Interventions: KidneyIntelX; Diagnostic Test
Lead sponsor: Renalytix AI, Inc.; Industry
Eligibility: 23 Years and older
Enrollment: 1,500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: Slingerlands, New York

Conditions: Intra Abdominal Infections, Appendicitis Acute, Pyelonephritis, Diverticulitis, Epiploic Appendagitis
Interventions: TruNAV, an RNA-based blood test for host immune activation by infections; Diagnostic Test
Lead sponsor: True Bearing Diagnostics, Inc.; Industry
Eligibility: 7 Years and older
Enrollment: 1,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Multiple Myeloma, Plasma Cell Neoplasm, Thromboembolism
Interventions: enzyme-linked immunosorbent assay, laboratory biomarker analysis, medical chart review; Other
Lead sponsor: UNC Lineberger Comprehensive Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2016
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Gastrointestinal Dysmotility
Interventions: Endoscopic procedure; Procedure
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years to 100 Years
Enrollment: 5 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Copy Number Variations
Interventions: MaterniT GENOME; Device
Lead sponsor: Sequenom, Inc.; Industry
Eligibility: 18 Years to 89 Years · Female only
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2018
U.S. locations: 1
States / cities: New York, New York

Conditions: COVID-19 Pandemic
Interventions: Diagnostic Test: IN Vitro; Diagnostic Test
Lead sponsor: 3EO Health; Industry
Eligibility: 2 Years and older
Enrollment: 202 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 4
States / cities: Miami, Florida • Humble, Texas • Kingwood, Texas

Conditions: Duchenne Muscular Dystrophy
Interventions: AAV8 DetectCDx; Diagnostic Test
Lead sponsor: REGENXBIO Inc.; Industry
Eligibility: 0 Years to 25 Years · Male only
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Coronary Heart Disease
Interventions: isolation of endothelial cells precursors in blood; Other
Lead sponsor: Tufts University; Other
Eligibility: 30 Years to 60 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Group A Streptococcus, Strep Throat
Interventions: In Vitro Diagnositc aid for diagnosis; Device
Lead sponsor: Quidel Corporation; Industry
Eligibility: 3 Years and older
Enrollment: 2,090 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 8
States / cities: Carlsbad, California • Panorama City, California • San Diego, California + 5 more

Conditions: Heart Failure
Interventions: In Vitro diagnostic tests; Device
Lead sponsor: Fujirebio Diagnostics, Inc.; Industry
Eligibility: 21 Years and older
Enrollment: 400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 2
States / cities: Baltimore, Maryland • Detroit, Michigan

Conditions: Allergy, Allergic Asthma, Allergy to Cats, Allergy to House Dust, Allergy to Dog Dander (Finding), Allergy Mold, Allergy Cockroach
Interventions: Blood Collection; Device
Lead sponsor: Abionic SA; Industry
Eligibility: 18 Years and older
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020
U.S. locations: 3
States / cities: Washington D.C., District of Columbia • Baltimore, Maryland • Cincinnati, Ohio

Conditions: Solid Tumor, Adult, Colorectal Cancer, NSCLC, Non Small Cell Lung Cancer, NSCLC, Recurrent, Non-Small Cell Squamous Lung Cancer, Pancreas Cancer, Pancreatic Neoplasm, Colorectal Adenocarcinoma, CRC, Colon Cancer, Rectal Cancer, Cancer, Ovarian Cancer, Ovarian Neoplasms, Mesothelioma, Mesothelioma, Malignant, Ovary Cancer, Lung Cancer, MESOM
Interventions: A2B694, A2B543, xT CDx with HLA-LOH Assay; Biological · Diagnostic Test
Lead sponsor: A2 Biotherapeutics Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 474 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2029
U.S. locations: 12
States / cities: Gilbert, Arizona • La Jolla, California • Los Angeles, California + 9 more

Conditions: Healthy
Interventions: Not listed
Lead sponsor: Nanomix; Industry
Eligibility: 18 Years and older
Enrollment: 160 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Cervical Cytology, PAP
Interventions: Digital cervical cytology slide imaging system with artificial intelligence (AI) algorithm in vitro diagnostic (IVD) device; Device
Lead sponsor: Techcyte, Inc.; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 4,596 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Orem, Utah

Conditions: Bacteremia, Staphylococcal Infection, Sepsis, Infection
Interventions: MicroPhage S. aureus / MSSA / MRSA Blood Culture Test (prototype); Other
Lead sponsor: MicroPhage, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 712 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008
U.S. locations: 3
States / cities: Evanston, Illinois • Baltimore, Maryland

Conditions: SARS (Severe Acute Respiratory Syndrome), Covid19
Interventions: The Pine Trees Health Test System; Diagnostic Test
Lead sponsor: Pine Trees, Inc.; Industry
Eligibility: 6 Years and older
Enrollment: 195 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021
U.S. locations: 3
States / cities: Spring Hill, Florida • Statesville, North Carolina • Redmond, Washington

Search by objective public record fields.

The PrISICE Clinical Trial (Pre-Implantation Screening and Investigation on the Cryopreservation of Embryos)

Eicosanoid Lipids by Airway Cells During Infection With Human Rhinoviruses

EXoPERT EMERALD Clinical Study

Clinical Performance Evaluation of the C2i-Test

Developing an In-vitro Diagnostic Risk-Stratification Test for Oral Cancer

Ovarian Tissue Freezing For Fertility Preservation

Clinical Evaluation of a Test for Monitoring the Recurrence of Bladder Cancer

Correlating Time-Lapse Parameters With aCGH Testing in IVF Treatment (aCGH Study)

Decision Impact Trial of KidneyIntelX

Diagnosis of Abdominal Pain Using RNA Levels: The NATURAL Study

Biomarkers Related to Thrombosis in Patients With Newly Diagnosed Multiple Myeloma Receiving Chemotherapy

Enteric Neural Precursor Cells (ENPC) in the Human Gut

Development of a NIPTT for Detecting Copy Number Variations

COVID-19 Molecular OTC At Home Test

AFFINITY BEYOND: Anti-AAV8 Antibody Assessment Study of Males With DMD

Endothelial Cell Gene Networks of CVD

Sofia Strep A FIA Field Study

Blood Collection of Patient Presenting in the ED and Prescribed a BNP

Analytical Validation of the abioSCOPE Device With an IgE Test Panel: Point-of-Care Precision, Sample Type Comparison and Method Correlation

A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression

Determination of Normal Reference Values of CRP, Procalcitonin, and Lactate Levels for the Nanōmix eLab® System

Techcyte SureView Cervical Cytology System Clinical Validation Study

MicroPhage S. Aureus / MSSA / MRSA Blood Culture Beta Trial

A Clinical Evaluation of Pine Trees Health Test System Including the Pine Trees Health Reader and COVID-19 Test for Point-of-Care